Premium
Triggering of apoptosis in osteosarcoma cells by graphene/single‐walled carbon nanotube hybrids via the ROS ‐mediated mitochondrial pathway
Author(s) -
Yan Xinxin,
Yang Wen,
Shao Zengwu,
Yang Shuhua,
Liu Xianzhe
Publication year - 2017
Publication title -
journal of biomedical materials research part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 150
eISSN - 1552-4965
pISSN - 1549-3296
DOI - 10.1002/jbm.a.35918
Subject(s) - materials science , cytotoxicity , apoptosis , carbon nanotube , graphene , reactive oxygen species , biodistribution , in vivo , nanotechnology , biophysics , microbiology and biotechnology , biology , in vitro , biochemistry
Carbon nanomaterials are increasingly significant in the biological and medical fields, especially becoming promising candidates in treating difficult and complicated disease. Graphene/single‐walled carbon nanotubes (G/SWCNT) hybrids is 3D structure which has been constructed by combining 1D single‐walled carbon nanotubes (SWCNTs) and 2D graphene. However, the effects of the nanomaterial on biological systems are limited. In this study, we report a systematic investigation of the cytotoxicity and in vivo biodistribution of G/SWCNT hybrids on osteosarcoma cells (HOS and U2OS). The CCK‐8, neutral red, and lactic dehydrogenase assays demonstrated that the cytotoxicity of G/SWCNT hybrids exhibits a dose‐dependent behavior on osteosarcoma cells. In our conditions, the hybrids were less cytotoxic than graphene and single‐walled carbon nanotubes. The results also showed the apoptosis of osteosarcoma cells induced by G/SWCNT hybrids was through the increase of intracellular reactive oxygen species, the decrease of mitochondrial membrane potential, the alternation of apoptosis‐related proteins, and then triggered the ROS‐mediated mitochondrial pathway. Moreover, the in vivo biodistribution of G/SWCNT hybrids was observed by histological analysis of major organs in mice, and showed that organs were neither damaged nor inflammatory. This study demonstrated that G/SWCNT hybrids could serve as a potential platform in anticancer therapy. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 443–453, 2017.